National Health Determination under paragraph 98C(1)(b) Amendment 2014 (No. 2)

Link to law: https://www.comlaw.gov.au/Details/F2014L00144

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
PB 10 of 2014
 
National Health Determination under paragraph 98C(1)(b) Amendment 2014
(No. 2)
_____________________________________________________________________
 
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated 12th February 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
1              Name of Instrument
(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2014 (No. 2).
(2)                This Instrument may also be cited as PB 10 of 2014.
2              Commencement                                                        
                This instrument commences on 1 March 2014.
3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]        Schedule 4, after entry for Bimatoprost in the form Eye drops 300 micrograms per mL, 3 mL
insert in the column headed “Form (strength, type, size, etc.)”:
 
Eye drops 300 micrograms per mL, single dose units 0.4 mL, 30
[2]        Schedule 4, omit entry for Terbutaline